Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, is working with Techcyte, a leading provider of a clinical pathology A.I. platform, to advance clinical pathology by improving whole slide imaging of non-histology samples.

December 17, 2021 — Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, is working with Techcyte, a leading provider of a clinical pathology A.I. platform, to advance clinical pathology by improving whole slide imaging of non-histology samples.

Digital pathology is generally associated with anatomic pathology and histology. However, the ability to scan non-histology samples will help medium- and high-throughput laboratories maximize the utility of whole slide scanners. Furthermore, advances in artificial intelligence (AI) are increasing the accuracy and efficiency of anatomic and clinical pathology tests.

Unlike histology slides, slides prepared with liquids and smears can be extremely difficult to digitize because they can be sparse and non-uniform. To overcome these obstacles and expand the scanning capability, Techcyte uses Hamamatsu's API (application programming interface) to improve the scanning of human and vet fecal samples, blood smears, pap smears, bacteriology samples, and airborne mold. The Hamamatsu API enables Techcyte to use A.I. and computer vision techniques to pre-scan and locate optimal scan regions to improve focus. This new approach increases the quality and decreases the file size of the resulting image, further improving the upload and analysis time.

The collaboration between Hamamatsu and Techcyte will first be used in labs to digitize and identify human fecal ova & parasites, cervical cytology, and mold samples, with other sample types and tests to follow quickly. Ben Cahoon, CEO of Techcyte, stated, "Great A.I. algorithms and workflows depend on great images, so collaborating with Hamamatsu to improve whole slide imaging is critical to our success. Hamamatsu's willingness to share their scanner API sets the example of how the two industries can collaborate to improve human health."

Scott Blakely, Business Development Manager at Hamamatsu, stated that, "This collaboration will grow the opportunity where our high-volume scanners can be used to benefit labs, and ultimately the patient, with quicker and more accurate results."

For more information: www.nanozoomer.com

Related Content

News | Information Technology

June 29, 2022 — Bayer unveiled Calantic Digital Solutions, a new cloud-hosted platform delivering access to digital ...

Time June 29, 2022
arrow
News | Ultrasound Imaging

June 28, 2022 — Mindray, a global leader and developer of healthcare technologies and solutions for ultrasound, patient ...

Time June 28, 2022
arrow
News | Radiology Business

June 22, 2022 — Blackford, a medical imaging AI platform leader that helps healthcare professionals add clinical value ...

Time June 22, 2022
arrow
News | Radiation Therapy

June 17, 2022 — Accuray Incorporated and Limbus AI Inc. announced they are partnering to augment Accuray adaptive ...

Time June 17, 2022
arrow
News | Artificial Intelligence

June 14, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), incorporating AI support into clinical ...

Time June 14, 2022
arrow
News | Artificial Intelligence

June 9, 2022 — Infinitt North America and Brainreader A/S announced today a wide ranging and unique partnership to ...

Time June 09, 2022
arrow
News | Digital Pathology

June 8, 2022 — Proscia, a leader in digital and computational pathology solutions, announced that its Concentriq Dx ...

Time June 08, 2022
arrow
News | Artificial Intelligence

May 31, 2022 — Median Technologies announces that the company is expanding its portfolio of services with Imaging Lab, a ...

Time May 31, 2022
arrow
News | Artificial Intelligence

May 31, 2022 — Patient trust is not a barrier to artificial intelligence (AI) adoption by medical imaging professionals ...

Time May 31, 2022
arrow
News | Artificial Intelligence

May 31, 2022 — Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, announced it has submitted an FDA 510(k) ...

Time May 31, 2022
arrow
Subscribe Now